More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.68B
EPS
0.31
P/E ratio
--
Price to sales
5.95
Dividend yield
--
Beta
1.053197
Previous close
$11.12
Today's open
$11.04
Day's range
$10.43 - $11.07
52 week range
$9.58 - $19.39
show more
CEO
Shiven Ramji
Employees
1285
Headquarters
Petah Tikva,
Exchange
Nasdaq Global Select
Shares outstanding
251341060
Issue type
Common Stock
Technology
Software & IT Services
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Cellebrite DI (CLBT)
Cellebrite DI (NASDAQ: CLBT) shares swung from an early earnings-day gain to a loss of about 14% on November 12, 2026, as the Company again lowered its full-year revenue guidance. Shareholders who took losses in that reversal may have legal rights. Cellebrite DI (NASDAQ: CLBT) shares swung from an early earnings-day gain to a loss of about 14% on November 12, 2026, as the Company again lowered its full-year revenue guidance. Shareholders who took losses in that reversal may have legal rights.
GlobeNewsWire • 16 hours ago

Cellebrite DI: Continuous Innovation Including AI Can Drive Growth
Cellebrite DI combines double-digit growth and an attractive valuation, positioning the stock for a potential reversal of its multiyear downtrend. Q3 revenue rose 18% to $149 million and ARR increased 20% to $528.5 million, supported by federal and international demand. CLBT raised 2026 adjusted EBITDA guidance to $163 million–$166 million.
Seeking Alpha • Nov 16, 2026

Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)
Cellebrite DI reported third-quarter results above key estimates on November 12, 2026, yet its shares traded down about 14% after the same report trimmed full-year revenue guidance again. Investors who lost money in the reversal may have legal rights.
PRNewsWire • Nov 13, 2026

Cellebrite DI Q3 Earnings Call Highlights
Cellebrite DI NASDAQ: CLBT reported third-quarter revenue and annual recurring revenue growth of 18% and 20%, respectively, as international sales and improving U.S. federal demand helped the digital forensics company exceed its guidance.
MarketBeat • Nov 12, 2026

Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call Transcript
Cellebrite DI Ltd. ( CLBT ) Q3 2026 Earnings Call November 12, 2026 8:30 AM EST Company Participants Andrew Kramer - VP of Investor Relations & Treasury Shiven Ramji - CEO & Director David Barter - Chief Financial Officer Marcus Jewell - Global Chief Revenue Officer Conference Call Participants Shaul Eyal - TD Cowen, Research Division Bhavin Shah - Deutsche Bank AG, Research Division Eric Martinuzzi - Lake Street Capital Markets, LLC, Research Division Jeff Van Rhee - Craig-Hallum Capital Group LLC, Research Division Brian Essex - JPMorgan Chase & Co, Research Division Rudy Kessinger - D.A.
Seeking Alpha • Nov 12, 2026

Cellebrite Reports Third-Quarter 2026 Results
Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 12, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
PRNewsWire • Nov 12, 2026

Cellebrite DI Ltd. (CLBT) Q3 Earnings Meet Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate.
Zacks Investment Research • Nov 12, 2026

Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 9, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it will report its third-quarter 2026 financial results before the U.S. markets open on Thursday, November 12, 2026, which is unchanged from its October 20, 2026 announcement.
PRNewsWire • Nov 9, 2026

Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development
Former Okta and SAP strategy leader brings AI, platform and M&A expertise to accelerate Cellebrite's growth TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 5, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the appointment of Rogerio Rizzi as executive vice president of Corporate Strategy and Development.
PRNewsWire • Nov 5, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
PRNewsWire • Oct 22, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Cellebrite DI Ltd. commission-free¹. Build wealth for the long term using automated trading and transfers.